GREAT POINT PARTNERS LLC

13F Filings History

Latest 13F report
Q4 2024 - Feb 14, 2025
Value $
$212M
Notable people
Mr. David Kroin, Dr. Jeffrey R. Jay, Ortav Yehudai, Lillian Nordahl
Signature - Title
Dr. Jeffrey R. Jay, M.D. - Senior Managing Member
Location
Greenwich, CT
Summary
This page shows a list of all the recent 13F filings made by GREAT POINT PARTNERS LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. GREAT POINT PARTNERS LLC reported 26 stock holdings with total value $212M as of Q4 2024. Top holdings included IONS, CYTK, KALV, VRDN, and PLRX.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2024 26 $212M +$41.4M -$103M -$61.5M IONS, CYTK, KALV, VRDN, PLRX 13F-HR 2/14/2025, 04:13 PM
Q3 2024 29 $331M +$32.6M -$227M -$195M NGNE, ABVX, PLRX, EOLS, VRDN 13F-HR 11/13/2024, 04:16 PM
Q2 2024 33 $522M +$165M -$250M -$84.5M URGN, NGNE, ABVX, MRUS, PLRX 13F-HR 8/14/2024, 04:38 PM
Q1 2024 33 $567M +$209M -$294M -$85.1M NGNE, ALPN, EOLS, PLRX, APGE 13F-HR 5/15/2024, 04:24 PM
Q4 2023 34 $587M +$114M -$189M -$74.9M ALPN, CYTK, URGN, PLRX, RARE 13F-HR 2/14/2024, 04:07 PM
Q3 2023 55 $549M +$183M -$104M +$78.6M URGN, ALPN, PLRX, PCVX, RARE 13F-HR 11/14/2023, 04:16 PM
Q2 2023 56 $511M +$147M -$150M -$3.67M ALPN, RARE, PCVX, PLRX, RAPT 13F-HR 8/14/2023, 05:17 PM
Q1 2023 44 $509M +$184M -$50.3M +$134M PLRX, XENE, ALPN, RARE, RAPT 13F-HR 5/15/2023, 04:09 PM
Q4 2022 42 $510M +$245M -$45.2M +$200M PCVX, XENE, RAPT, ALPN, PLRX 13F-HR 2/14/2023, 03:02 PM
Q3 2022 39 $406M +$146M -$67.6M +$77.9M XENE, JAZZ, PNT, ALPN, TVTX 13F-HR 11/14/2022, 03:24 PM
Q2 2022 34 $406M +$157M -$28.8M +$128M XENE, JAZZ, CYTK, TVTX, ALNY 13F-HR 8/15/2022, 04:25 PM
Q1 2022 30 $414M +$137M -$20.7M +$116M EXEL, XENE, TVTX, BCYC, JAZZ 13F-HR 5/16/2022, 04:24 PM
Q4 2021 36 $450M +$173M -$13.1M +$160M ARNA, EXEL, XENE, TVTX, ANAB 13F-HR 2/14/2022, 10:22 AM
Q3 2021 35 $423M +$155M -$169M -$13.6M EXEL, ARNA, KDMN, BCAB, RCKT 13F-HR 11/15/2021, 04:36 PM
Q2 2021 28 $447M +$140M -$146M -$6.87M MGNX, RCKT, ARNA, UTHR, PODD 13F-HR 8/16/2021, 04:33 PM
Q1 2021 28 $484M +$165M -$241M -$75.9M MGNX, RCKT, IOVA, SAGE, XENT 13F-HR 5/17/2021, 04:05 PM
Q4 2020 33 $616M +$181M -$641M -$460M GWPH, IOVA, SAGE, ACAD, RCKT 13F-HR 2/16/2021, 03:17 PM
Q3 2020 34 $1.11B +$180M -$191M -$11.1M IOVA, SAGE, ACAD, ARNA, ZYME 13F-HR 11/16/2020, 03:41 PM
Q2 2020 36 $1.25B +$480M -$138M +$342M CNST, IOVA, ZYME, ACAD, SAGE 13F-HR 8/14/2020, 04:55 PM
Q1 2020 36 $957M +$319M -$222M +$96.8M ACAD, ZYME, PTCT, IOVA, CNST 13F-HR 5/15/2020, 04:04 PM
Q4 2019 37 $1.15B +$460M -$264M +$197M IOVA, ZYME, PTCT, AXSM, NXTC 13F-HR 2/14/2020, 03:17 PM
Q3 2019 41 $1.09B +$443M -$45.6M +$397M IOVA, ZGNX, ACAD, BOLD, PTCT 13F-HR 11/15/2019, 01:01 PM
Q2 2019 30 $901M +$305M -$49.2M +$255M IOVA, PTCT, ZGNX, BOLD, KURA 13F-HR 8/14/2019, 04:05 PM
Q1 2019 40 $1.01B +$263M -$80.7M +$183M PTCT, ZGNX, GBT, BOLD, ACAD 13F-HR 5/14/2019, 04:05 PM
Q4 2018 40 $791M +$419M -$52M +$367M BCRX, IOVA, GBT, XLRN, ACAD 13F-HR 2/14/2019, 08:01 PM
Q3 2018 30 $642M +$184M -$88.3M +$95.9M BCRX, XLRN, ZFGN, IOVA, UTHR 13F-HR 11/14/2018, 03:00 PM
Q2 2018 38 $722M +$290M -$69M +$221M PTCT, KURA, IOVA, BCRX, ONCE 13F-HR 8/14/2018, 04:00 PM
Q1 2018 37 $673M +$241M -$35.4M +$206M IOVA, ARNA, KURA, PTCT, ZGNX 13F-HR 5/14/2018, 04:00 PM
Q4 2017 39 $586M +$235M -$62.8M +$172M ZGNX, ARNA, KURA, SAGE, GBT 13F-HR 2/14/2018, 03:10 PM
Q3 2017 37 $514M +$181M -$221M -$39.9M ZGNX, UTHR, ARNA, CNCE, ALNY 13F-HR 11/14/2017, 03:02 PM
Q2 2017 38 $558M +$188M -$51.4M +$136M ARNA, ADMS, VNDA, ZGNX, PTCT 13F-HR 8/14/2017, 04:12 PM
Q1 2017 37 $504M +$204M -$76.3M +$128M ADMS, CNCE, SGYPQ, VNDA, RIGL 13F-HR 5/15/2017, 04:00 PM
Q4 2016 35 $487M +$158M -$37.8M +$120M ADMS, FOMX, VNDA, SGYPQ, ZGNX 13F-HR 2/14/2017, 03:06 PM
Q3 2016 34 $390M +$116M -$24.4M +$91.2M VNDA, ADMS, SGYPQ, ZGNX, FOMX 13F-HR 11/14/2016, 04:31 PM
Q2 2016 39 $349M +$132M -$26.1M +$106M ADMS, VNDA, SGYPQ, EXEL, DERM 13F-HR 8/15/2016, 04:08 PM
Q1 2016 33 $279M +$112M -$1.16M +$110M ADMS, FPRX, VNDA, ZGNX, TTPHXXXX 13F-HR 5/16/2016, 03:02 PM
Q4 2015 24 $234M +$39.1M -$29.4M +$9.68M ADMS, FPRX, ZGNX, VNDA, TTPHXXXX 13F-HR 2/16/2016, 12:21 PM
Q3 2015 36 $252M +$109M -$9.15M +$99.8M VNDA, FPRX, CNXR, ADMS, ZGNX 13F-HR 11/16/2015, 09:58 AM
Q2 2015 34 $257M +$106M -$23.2M +$82.8M CNXR, ADMS, VNDA, FPRX, SGYPQ 13F-HR 8/14/2015, 01:11 PM
Q1 2015 33 $227M +$81.9M -$40.9M +$41M CNXR, HPTX, VNDA, OFIX, ADMS 13F-HR 5/15/2015, 11:49 AM
Q4 2014 26 $198M +$86.1M -$26.2M +$59.9M CNXR, HPTX, ALIM, OCRX, DSCI 13F-HR 2/17/2015, 08:19 AM
Q3 2014 37 $233M +$93M -$24.9M +$68.2M HPTX, NBIX, INFI, ALIM, OPHT 13F-HR 11/14/2014, 09:26 AM
Q2 2014 38 $225M +$97.6M -$12.5M +$85.1M NBIX, HPTX, DSCI, THOR, INFI 13F-HR 8/14/2014, 04:17 PM
Q1 2014 36 $191M +$94.2M -$34.2M +$60M FURX, HPTX, PTIE, ALIM, DSCI 13F-HR 5/15/2014, 04:30 PM
Q4 2013 26 $126M HPTX, PTIE, FURX, OCRX, INFI 13F-HR 2/14/2014, 05:17 AM